CD4 + CD25 + FOXP3 + Regulatory T Cells Suppress Anti-Tumor Immune Responses in Patients with Colorectal Cancer
Sarah L. Clarke, Gareth J. Betts, Andrea Plant et al. · 2006
Read CD4 + CD25 + FOXP3 + Regulatory T Cells Suppress Anti-Tumor Immune Responses in Patients with Colorectal Cancer by Sarah L. Clarke, Gareth J. Betts, Andrea Plant et al. (2006) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0000129.txt.
Description
Sarah L. Clarke, Gareth J. Betts, Andrea Plant, and colleagues published this immunology study in PLOS ONE in 2006. It concerns colorectal cancer patients and a special set of immune cells called regulatory T cells, marked by CD4, CD25, and FOXP3. These cells normally calm immune responses down.
The authors report that these regulatory cells suppress the immune attack against the tumor in these patients. That helps explain how cancers can grow in a body that has a working immune system. The finding is relevant to cancer immunotherapy, where lifting such brakes is a main strategy for freeing the immune system to fight.
Catalog record
| CREATOR | Sarah L. Clarke, Gareth J. Betts, Andrea Plant et al. |
|---|---|
| YEAR | 2006 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 28 KB |
| LICENSE | Creative Commons Attribution License |
| RIGHTS | CC BY |
| SOURCE | PLOS ONE |
Source: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0000129